KR101168292B1 - 단클론 항체, 하이브리도마, 단백질 ｐｔｘ3 측정을 위한 개량 방법 및 상기 측정용 키트 - Google Patents

단클론 항체, 하이브리도마, 단백질 ｐｔｘ3 측정을 위한 개량 방법 및 상기 측정용 키트 Download PDF

Info

Publication number
KR101168292B1
KR101168292B1 KR1020067024272A KR20067024272A KR101168292B1 KR 101168292 B1 KR101168292 B1 KR 101168292B1 KR 1020067024272 A KR1020067024272 A KR 1020067024272A KR 20067024272 A KR20067024272 A KR 20067024272A KR 101168292 B1 KR101168292 B1 KR 101168292B1
Authority
KR
South Korea
Prior art keywords
ptx3
solution
well
kit
buffer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020067024272A
Other languages
English (en)
Korean (ko)
Other versions
KR20070006914A (ko
Inventor
알베르토 만토바니
쥬세페 페리
Original Assignee
파르마 디벨로프먼트 에스 알 엘
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 파르마 디벨로프먼트 에스 알 엘 filed Critical 파르마 디벨로프먼트 에스 알 엘
Publication of KR20070006914A publication Critical patent/KR20070006914A/ko
Application granted granted Critical
Publication of KR101168292B1 publication Critical patent/KR101168292B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
KR1020067024272A 2004-04-29 2005-04-27 단클론 항체, 하이브리도마, 단백질 ｐｔｘ3 측정을 위한 개량 방법 및 상기 측정용 키트 Expired - Fee Related KR101168292B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000858A ITMI20040858A1 (it) 2004-04-29 2004-04-29 Anticorpi monoclonali ibridomi metodo migliorato per determinare la proteina ptx3 e kit per detta determinazione
ITMI2004A000858 2004-04-29
PCT/EP2005/004637 WO2005106494A2 (en) 2004-04-29 2005-04-27 Monoclonal antibodies, hybridomas, improved method for determining the protein ptx3 and kit for said determination

Publications (2)

Publication Number Publication Date
KR20070006914A KR20070006914A (ko) 2007-01-11
KR101168292B1 true KR101168292B1 (ko) 2012-07-25

Family

ID=35242298

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020067024272A Expired - Fee Related KR101168292B1 (ko) 2004-04-29 2005-04-27 단클론 항체, 하이브리도마, 단백질 ｐｔｘ3 측정을 위한 개량 방법 및 상기 측정용 키트

Country Status (9)

Country Link
US (1) US7915004B2 (enExample)
EP (1) EP1740956A2 (enExample)
JP (2) JP2007534951A (enExample)
KR (1) KR101168292B1 (enExample)
CN (1) CN1947018B (enExample)
AU (1) AU2005238637B2 (enExample)
CA (1) CA2562895A1 (enExample)
IT (1) ITMI20040858A1 (enExample)
WO (1) WO2005106494A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1947460B1 (en) * 2005-11-11 2012-05-30 The University of Tokyo Method of measuring ptx3 with high sensitivity
JP5199120B2 (ja) * 2005-12-29 2013-05-15 ヒューマニタス・ミラソーレ・エス．ピー．エー． 妊娠における炎症性内皮機能障害に対する診断試験
ATE475098T1 (de) * 2006-12-22 2010-08-15 Humanitas Mirasole Spa Verfahren zur messung von plasmaspiegeln von pentraxin ptx3
WO2008099608A1 (ja) * 2007-02-15 2008-08-21 Saitama Medical University 炎症性腸疾患の診断方法
JP5832479B2 (ja) 2012-08-09 2015-12-16 日本特殊陶業株式会社 ガスセンサ
TWI528969B (zh) * 2013-06-07 2016-04-11 國立成功大學 胺基酸序列用於製備抑制ｐｔｘ３治療鼻咽癌之醫藥組合物之用途
CN106950366B (zh) * 2017-02-15 2019-03-22 中国医学科学院北京协和医院 一种acpa阴性的ra诊断标志物及其应用
TWI741216B (zh) * 2017-09-19 2021-10-01 臻崴生物科技有限公司 專一性抑制或減緩ｐｔｘ３與ｐｔｘ３受體結合之單株抗體或其抗原結合片段及其用途
TWI754171B (zh) 2018-09-14 2022-02-01 臻崴生物科技有限公司 含單株抗體或其抗原結合片段之醫藥組成物及其用途
CN111024956A (zh) * 2019-12-31 2020-04-17 江苏美克医学技术有限公司 一种检测ptx3的时间分辨荧光免疫层析试剂盒
US20230251274A1 (en) * 2020-06-25 2023-08-10 Humanitas Mirasole S.P.A. Ptx3 as prognostic marker in covid-19

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003072603A2 (en) 2002-02-28 2003-09-04 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05340945A (ja) * 1992-06-05 1993-12-24 Shiseido Co Ltd 微量物質測定方法及び測定キット
JPH0875737A (ja) * 1994-09-06 1996-03-22 Fuji Yakuhin Kogyo Kk ヒト前立腺特異抗原とヒトプロテインｃインヒビターとの複合体の測定方法および同測定用キット
JPH09220096A (ja) * 1996-02-16 1997-08-26 Meiji Milk Prod Co Ltd コレラトキシン及びその中和活性の新規 高感度測定法及び同キット
JP4427182B2 (ja) * 1997-09-22 2010-03-03 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 抗原を安定化するための緩衝液
JP2002014098A (ja) * 2000-06-28 2002-01-18 Fujirebio Inc 免疫測定方法及びそのためのキット
US20040137544A1 (en) 2002-10-31 2004-07-15 Roberto Latini PTX3 as an early prognostic indicator of cardiovascular and cerebrovascular pathologies
JP4667372B2 (ja) * 2004-02-25 2011-04-13 株式会社ペルセウスプロテオミクス 血管障害の程度の判定方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003072603A2 (en) 2002-02-28 2003-09-04 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ARTHRITIS RAEUM, vol.44, no.12, December 2001, pages 2841-2850

Also Published As

Publication number Publication date
US20080261251A1 (en) 2008-10-23
JP2007534951A (ja) 2007-11-29
WO2005106494A3 (en) 2006-06-01
CN1947018A (zh) 2007-04-11
ITMI20040858A1 (it) 2004-07-29
JP2011117973A (ja) 2011-06-16
WO2005106494A2 (en) 2005-11-10
EP1740956A2 (en) 2007-01-10
AU2005238637A1 (en) 2005-11-10
KR20070006914A (ko) 2007-01-11
US7915004B2 (en) 2011-03-29
CN1947018B (zh) 2012-12-19
CA2562895A1 (en) 2005-11-10
AU2005238637B2 (en) 2010-12-16

Similar Documents

Publication Publication Date Title
Yamaoka–Tojo et al. Circulating levels of interleukin 18 reflect etiologies of heart failure: Th1/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failure
JP2011117973A (ja) タンパク質ｐｔｘ３測定用の単クローン抗体、ハイブリドーマ、改良方法、及び前記測定用キット
ES2542343T3 (es) Diagnóstico diferencial entre enfermedad pulmonar y cardiovascular
KR101067817B1 (ko) Ａｉｍｐ1 폴리펩티드에 대한 항체를 포함하는 관절염 진단용 조성물
EP2021799B1 (en) Interleukin-33 (il-33) for the diagnosis and prognosis of cardiovascular disease
KR20110104930A (ko) 갈렉틴-３ 면역검정
JP2007510892A (ja) 冠動脈疾患の危険性を層別化するための動脈血栓および炎症の基部マーカー
EP2673646B1 (en) Diagnostic method for urinary tract infection
KR20140045409A (ko) 초기 류마티스성 관절염의 진단 방법
EP0710839A2 (en) Method of measuring interferon activity
EP3002588B1 (en) Use of a biomarker for diagnosing schizophrenia
EP2092342B1 (en) A method for measuring plasma levels of pentraxin ptx3
US7550269B2 (en) PTX3 as an early prognostic indicator of cardiovascular and cerebrovascular pathologies
EP3521827A1 (en) Inspection method enabling specific diagnosis of pathological state of diabetic nephropathy at early stage
CN100572391C (zh) β-胞衬蛋白抗原表位多肽及其筛选方法与应用
JP3045172B2 (ja) Ｉｌ―６レセプターを利用したヒトｉｌ―６の化学的測定法及びそのためのキット
WO2006068059A1 (ja) 色素上皮由来因子の定量法
US20090081714A1 (en) Assays
Manual Human Procalcitonin EIA Kit
De Benedetti Measurement of cytokines in synovial fluid
JP2008286599A (ja) エリスロポエチン応答性の診断方法

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R14-asn-PN2301

R17-X000 Change to representative recorded

St.27 status event code: A-5-5-R10-R17-oth-X000

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20150719

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20150719